Shareholders' equity · 2011–2025
Elite Pharmaceuticals shareholders' equity
$80.3M+120.4% · FY2025
Elite Pharmaceuticals (ELTP) reported $80.3M in shareholders' equity for fiscal 2025, +120.4% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $80.3M | +120.4% | Open → |
| FY20242024-12-31 | $36.4M | −21.5% | Open → |
| FY20232023-12-31 | $46.4M | +53.8% | Open → |
| FY20222022-12-31 | $30.2M | +32.4% | Open → |
| FY20212021-12-31 | $22.8M | +37.0% | Open → |
| FY20202020-12-31 | $16.6M | +83.2% | Open → |
| FY20192019-12-31 | $9.1M | +$9.3M | Open → |
| FY20182018-12-31 | −$264,594 | −$6.3M | Open → |
| FY20172017-12-31 | $6.0M | −77.0% | Open → |
| FY20162016-12-31 | $26.0M | +$86.5M | Open → |
| FY20152015-12-31 | −$60.5M | −$30.0M | Open → |
| FY20142014-12-31 | −$30.5M | −$25.6M | Open → |
| FY20132013-12-31 | −$4.9M | +$7.4M | Open → |
| FY20122012-12-31 | −$12.4M | +$2.0M | Open → |
| FY20112011-12-31 | −$14.3M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Elite Pharmaceuticals shareholders' equity |url=https://companiesranked.com/en/company/elite-pharmaceuticals/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Elite Pharmaceuticals shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/elite-pharmaceuticals/shareholders-equityBibTeX
@misc{companiesranked-en-company-elite-pharmaceuticals-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Elite Pharmaceuticals shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/elite-pharmaceuticals/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001493152-26-007104 · February 17, 2026
{{cite web |title=Elite Pharmaceuticals shareholders' equity — 10-Q (0001493152-26-007104) |url=https://www.sec.gov/Archives/edgar/data/1053369/000149315226007104/form10-q.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-17}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.